FOXP3 and non-small cell lung carcinoma: Jiang et al. found a suppressive function of miR-532-3p in non-small cell lung cancer (NSCLC) by targeting FOXP3, revealing that the miR-532-3p/FOXP3 axis might be a potential therapeutic target for the treatment of NSCLC [30].